MARKET

TRXC

TRXC

TRANSENTERIX
AMEX

Real-time Quotes | Nasdaq Last Sale

0.3749
-0.0074
-1.94%
Opening 09:52 10/30 EDT
OPEN
0.3849
PREV CLOSE
0.3823
HIGH
0.3849
LOW
0.3711
VOLUME
32.81K
TURNOVER
--
52 WEEK HIGH
4.420
52 WEEK LOW
0.2800
MARKET CAP
37.44M
P/E (TTM)
-0.0528
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
TransEnterix (TRXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
TransEnterix (TRXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 21h ago
TransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 5, 2020
TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Thursday, November 5, 2020. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day. The call will be concurrently webcast.
Business Wire · 4d ago
ROCE Insights For TransEnterix, Inc. Common Stock
During Q2, TransEnterix, Inc. Common Stock (AMEX: TRXC) brought in sales totaling $655.00 thousand. However, earnings decreased 16.24%, resulting in a loss of $14.37 million. In Q1, TransEnterix, Inc. Common Stock brought in $600.00 thousand in sales but lost $17.15 million in earnings.What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company's ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q2, TransEnterix, Inc. Common Stock posted an ROCE of -0.24%.Keep in mind, while ROCE is a good measure of a company's recent performance, it is not a highly reliable predictor of a company's earnings or sales in the near future.View more earnings on TRXCReturn on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.In TransEnterix, Inc. Common Stock's case, the ROCE ratio shows the amount of assets may not be helping the company achieve higher returns. Investors may take this into account before making any long-term financial decisions.Q2 Earnings Insight TransEnterix, Inc. Common Stock reported Q2 earnings per share at $-0.21/share, which beat analyst predictions of $-0.38/share.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Looking Into TransEnterix, Inc. Common Stock's Return On Capital Employed(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga · 10/13 14:49
TransEnterix +15% PM, marks first time use of 3 mm instruments in robotic pediatric surgery
TransEnterix (TRXC) announces that surgeons at Maastricht University Medical Center+ (or MUMC+) in the Netherlands, have successfully utilized the Senhance® Surgical System and integrate digital laparoscopy with instruments as small as 3 mm
Seekingalpha · 10/13 12:42
TransEnterix Announces First Pediatric Surgical Cases with Senhance® Surgical System
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that surgeons at Maastricht University Medical Center+ (MUMC+) in the Netherlands, have successfully operated on multiple pediatric patients, becoming the first pediatric surgical program in the world to utilize the Senhance® Surgical System and integrate digital laparoscopy with instruments as small as 3 mm into their standard of surgical care.
Business Wire · 10/13 11:55
TransEnterix Announces First Pediatric Surgical Cases With Senhance Surgical System At Maastricht University Medical Center+ In The Netherlands
Pediatric Patients Successfully Treated Utilizing 3mm Instruments on Digital Laparoscopy Platform RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE:TRXC), a medical device company that is
Benzinga · 10/13 10:56
Looking Into TransEnterix, Inc. Common Stock's Return On Capital Employed
During Q2, TransEnterix, Inc. Common Stock (AMEX: TRXC) brought in sales totaling $655.00 thousand. However, earnings decreased 16.24%, resulting in a loss of $14.37 million. TransEnterix, Inc. Common Stock collected $600.00 thousand in revenue during Q1, but reported earnings showed a $17.15 million
Benzinga · 10/07 15:20
TransEnterix Announces Toshima Hospital In Japan Will Initiate Digital Laparoscopy Program Utilizing A Senhance Surgical System
Japan is One of the Fastest Growing Markets for Senhance Surgical System TransEnterix, Inc. (NYSE:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally
Benzinga · 10/07 10:58
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TRXC. Analyze the recent business situations of TRANSENTERIX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TRXC stock price target is 1.750 with a high estimate of 1.750 and a low estimate of 1.750.
EPS
Institutional Holdings
Institutions: 157
Institutional Holdings: 73.36M
% Owned: 73.45%
Shares Outstanding: 99.88M
TypeInstitutionsShares
Increased
45
6.91M
New
19
2.21M
Decreased
31
11.32M
Sold Out
24
1.40M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.62%
Healthcare Equipment & Supplies
-0.57%
Key Executives
Chairman/Independent Director
Paul LaViolette
President/Chief Executive Officer/Director
Anthony Fernando
Chief Financial Officer/Executive Vice President
Shameze Rampertab
Independent Director
Andrea Biffi
Independent Director
Jane Hsiao
Independent Director
William Kelley
Independent Director
David Milne
Independent Director
Richard Pfenniger
Independent Director
William Starling
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About TRXC
TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Transenterix Inc stock information, including AMEX:TRXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRXC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TRXC stock methods without spending real money on the virtual paper trading platform.